Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and Disease Exacerbation

cyc 202 has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haylor, J; Khwaja, A; Nutter, F1
Andersen, JM; Caffrey, TC; Collisson, EC; Eggers, JP; Grandgenett, PM; High, RR; Hollingsworth, MA; Lewallen, ME; Ouellette, M; Singh, PK; Swanson, BJ; Tremayne, J1
Deans, AJ; Heierhorst, J; Khanna, KK; McArthur, GA; McNees, CJ; Mercurio, C1
Bukanov, NO; Ibraghimov-Beskrovnaya, O; Klinger, KW; Ledbetter, SR; Smith, LA1

Other Studies

4 other study(ies) available for cyc 202 and Disease Exacerbation

ArticleYear
Seliciclib inhibits renal hypertrophy but not fibrosis in the rat following subtotal nephrectomy.
    Nephron. Experimental nephrology, 2012, Volume: 122, Issue:3-4

    Topics: Albuminuria; Animals; Cyclin A1; Cyclin-Dependent Kinase 2; Disease Progression; Extracellular Matrix; Fibrosis; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney; Nephrectomy; Purines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Roscovitine

2012
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Oct-01, Volume: 17, Issue:19

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Disease Progression; Enzyme Activation; Gene Amplification; Genes, ras; Humans; Mutation; Neoplasm Invasiveness; Nerve Tissue Proteins; Pancreatic Neoplasms; Purines; Roscovitine

2011
Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers.
    Cancer research, 2006, Aug-15, Volume: 66, Issue:16

    Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Disease Progression; DNA Damage; DNA Repair; DNA, Neoplasm; Female; Fibroblasts; Humans; Mice; Mice, Knockout; Purines; RNA, Neoplasm; RNA, Small Interfering; Roscovitine

2006
Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
    Nature, 2006, Dec-14, Volume: 444, Issue:7121

    Topics: Animals; Apoptosis; Cyclin-Dependent Kinases; Disease Models, Animal; Disease Progression; Kidney; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Polycystic Kidney Diseases; Purines; Roscovitine; Time Factors

2006